Global Veterinary Healthcare Market Report 2022



Key companies in the veterinary healthcare market include Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co, IDEXX Laboratories, Evonik Industries AG, Patterson Companies Inc., Ceva Animal Health LLC – Biomune; Pets at Home Group PLC, National Veterinary Associates and Phirbo Animal Health.

New York, May 26, 2022 (GLOBE NEWSWIRE) — announces the publication of the “Veterinary Healthcare Global Market Report 2022” –

The global veterinary healthcare market is expected to grow from $159.59 billion in 2021 to $176.96 billion in 2022 at a compound annual growth rate (CAGR) of 10.9%. The market is expected to reach $252.05 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%.

The veterinary healthcare market includes the sales of veterinary healthcare goods and services by entities (organizations, sole proprietorships, and partnerships) associated with the diagnosis, treatment, and prevention of disease in animals. This industry includes establishments that provide veterinary services, producers of veterinary medical equipment, and producers of animal drugs.

The main types of veterinary health care are veterinary services, veterinary medical equipment, animal medicine and are used for animals such as dogs and cats, horses, ruminants, pigs, poultry and other animals. other animals. Veterinary services refer to health services that are provided to animals.

Products include instruments/equipment, disposable products.

North America was the largest region in the veterinary healthcare market in 2021. Asia-Pacific was the second largest region in the veterinary healthcare market.

Regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Global meat production is expected to increase over the forecast period, supporting the growth of the veterinary healthcare market. According to the United States Department of Agriculture, in 2020, beef production in the United States reached 27.5 billion pounds, the highest production volume recorded in the country. The increase in meat production is particularly important in developing countries like China, India and Brazil, where increasing populations and rising income levels are driving demand for meat products. By 2027, meat and poultry production in emerging markets is expected to increase by 76%. By 2050, China’s meat imports are expected to increase by more than 3,500% to $150 billion, as consumption of chicken, pork and beef will increase due to the rise of the middle class in the country. The increase in the production of meat products supported by the growing population will increase the demand for feed additives in the livestock industry, driving the veterinary healthcare market.

The coronavirus disease (COVID-19) outbreak acted as a massive restraint on the veterinary healthcare market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments around the world. COVID-19 is an infectious disease with flu-like symptoms including fever, cough and difficulty breathing.

The virus was first identified in 2019 in Wuhan, Hubei Province in the People’s Republic of China, and has spread around the world, including Western Europe, North America and Asia. Measures taken by national governments to contain transmission have led to a decline in economic activity as countries enter a state of “lockdown” and the outbreak has hurt businesses throughout 2020 and into 2021. However, the veterinary healthcare market is expected to recover from the shock throughout the forecast period as it is a “black swan event” and not related to continued weaknesses. or fundamentals of the market or the global economy

Nanotechnology is gaining more and more traction in the animal medicine market as a substitute for veterinary antibiotics to combat antibiotic resistance. Nanotechnology is the study of controlling matter at the atomic and molecular scale.

Nanotechnology in the animal medicine industry is used to improve diagnosis, treatment, animal growth promotion and production. Nanoparticles are mainly used as alternative antimicrobial agents to reduce the use of antibiotics and improve the detection of pathogenic bacteria.

They are also used as drug delivery agents for new drug and vaccine candidates to improve their characteristics and performance, and to reduce drug resistance in animal organisms.

The countries covered in the veterinary healthcare market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, l Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel. , Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom, United States, Venezuela and Vietnam.

Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.


CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

Comments are closed.